[HISTOLOGICAL ANALYSIS OF BONE DESTRUCTION IN SPINAL TUBERCULOSIS]

Kekkaku : [Tuberculosis]
|October 20, 2015
PubMed
Abstract

Insights

Spinal tuberculosis (TB) activates the receptor activator of NF-κB (RANK) and RANK ligand (RANKL) pathway, leading to bone destruction. This pathway

Area of Science:

  • Immunohistochemistry
  • Molecular biology
  • Orthopedic pathology

Context:

  • Spinal tuberculosis (TB) is a destructive bone disease.
  • Understanding the molecular mechanisms of bone destruction in spinal TB is crucial for developing targeted therapies.
  • The receptor activator of NF-κB (RANK) signaling pathway plays a key role in bone remodeling.

Purpose:

  • To investigate the role of the RANK, RANKL, osteoprotegerin (OPG), and osteocalcin (OCN) pathway in spinal TB bone destruction.
  • To compare the expression of these markers in spinal TB tissues versus normal bone tissues.

Summary:

  • Spinal TB tissues showed significant inflammatory cell infiltration and osteoclast-mediated bone resorption.
  • The RANK-RANKL pathway was highly activated in spinal TB, with RANKL expressed in inflammatory cells and osteoblasts, and RANK in osteoclast precursors.
  • Bone formation markers (OCN) were reduced, and OPG, a RANKL inhibitor, was not sufficiently upregulated, indicating a net bone-resorptive state.

Impact:

  • Findings suggest that the activated RANK-RANKL pathway, potentially driven by TB-related cytokines, is a primary driver of bone destruction in spinal TB.
  • This study highlights the imbalance between bone resorption and formation in spinal TB.
  • Provides a molecular basis for understanding osteoarticular TB pathogenesis and suggests potential therapeutic targets.

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.1K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.5K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
704
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.4K